Language: BG BG
← Back to results
Active (not recruiting) Phase 1 NCT05727189

A Study of Idazoxan in Healthy Participants

Phase 1 – testing safety in a small group of people
Conditions: Healthy

Sponsor: Terran Biosciences Australia Pty Ltd

trial.available_in: БГ
Overview
Four-part study of the safety, tolerability and pharmacokinetics of 3 forms of TR-01-XRR, 1 form of TR-01-XRS, and 1 form of TR-01-XR in healthy adults.
Who can participate
Inclusion Criteria: * BMI between 18 and 32 kg/m2 * Medically healthy without clinically significant or relevant medical history Exclusion Criteria: * Evidence of recurrent disease, physical illness or medical condition that could affect action, absorption or disposition of investigational products * Use of any prescription or over-the-counter medication that cannot be discontinued for the duration of the study * Impaired renal function * Cardiac abnormalities * Positive HIV, HBsAg or HCV * Positive test for alcohol, drugs of abuse or cotinine
Locations 1
Australia (1)
Scientia Clinical Research
Randwick , New South Wales
Technical details
Status
Active (not recruiting)
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
55 Years
Healthy volunteers
No
Start date
14.02.2023
Completion date
01.12.2027
Registry ID
NCT05727189
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.